Quote:

---

The fact is the BLA was submitted on April 27, 2020. In the past 3 press releases under the About Leronlimab and BLA Submission for the HIV Combination Therapy section key verbiage explaining the BLA process was incorporated to address the timing and completeness of the filing.

“We would like to provide an update that the Biologics License Application (BLA) for Leronlimab as a Combination Therapy for Highly Treatment Experienced HIV Patients will be considered completed after the clinical datasets are submitted on May 11, 2020.

---